conferenceseries.com
Global Cancer 2018
Program Global Summit on
Oncology & Cancer
Theme: Redefining the Frontiers in Oncology Research March 12-14, 2018 Singapore
Seating is Limited Register Today! https://globalcancer.conferenceseries.com/
Conference Secretariat
Conference Series Kemp House, 152 City Road, London EC1V 2NX, Phone: +44 800 098 8455 Fax: + 44 203 004 1517 Email:
[email protected]
Day 1: March 12, 2018 08:30-09:00 Registration
conferenceseries.com
Seletar Room 1 Level 3
09:00-09:30
Opening Ceremony
Keynote Forum Title: Potential of recombinant protein (ULLB-0005) in different cancer Sudeep Kumar, Unichem Laboratories Ltd, India Title : Novel autoantibody signatures in plasma exosomes as potential biomarkers for diagnostics and 10:15-11:00 prognosis of non-small-cell lung cancer Lingzhi Wang, Cancer Science Institute of Singapore, Singapore Group Photo Networking & Refreshments Break 11:00-11:15 @ Seletar Foyer Title: CHD1L promotes lineage reversion of hepatocellular carcinoma through open chromatin for key 11:15-12:00 developmental transcription factors Ming Liu, Guangzhou Medical University, China Title : Pkc-δ phosphorylation of p62 is essential for VPS34-dependent breast cancer progression 12:00-12:45 Yonghua Yang, Fudan University School of Pharmacy, China Lunch Break 12:45-13:45 @ Atrium Restaurant Sessions: Cancer Treatment and Therapeutics |Cancer Pharmacology | Gynaecologic Oncology Session Chair: Yonghua Yang, Fudan University School of Pharmacy, China Session Co-chair: Ming Liu, Guangzhou Medical University, China Title: First in human report of intravenous infusion of Metavec (synthetic bacteriophage delivering 13:45-14:15 genetic cargo) in a patient with metastatic ovarian cancer Armand Sinclair, Novother Cancer Research, New Zealand Title: Abrogation of LBH589-induced autolysosome maturation by Mevastatin promotes cell death in 14:15-14:45 triple-negative breast cancer cells Xiaoxiao Jiang, Fudan University School of Pharmacy, China Title: Adjuvant hysterectomy after chemo radiation for residual disease of cancer cervix 14:45-15:15 Shahana Pervin, National Institute of Cancer Research & Hospital, Bangladesh Networking & Refreshments Break 15:15-15:30 @ Seletar Foyer 9:30-10:15
Poster Presentation @ 15:30 –17:30 GC–001 GC–002 GC–003 GC–004 GC–005
GC–006 GC–007
Title: Eight lines treatment in advanced stage NPC: A case report Dian Pratiwi, Dr. Sardjito Hospital, Indonesia Title: Comparative analysis of molecular signature in oral squamous cell carcinoma induced by Areca nut consumption Hui Ju Wu, La Sierra University, USA Title: Stereotactic radiotherapy for unresectable hepatocellular carcinoma: A review Komal Prabhu, Westmead Hospital, Australia Title: Effect of molecular weight of fucoidan on its anticancer-activity Jong-il CHOI, Chonnam National University, South Korea Title: Breast cancer-targeted delivery of BRCA1 and BRCA2 tumor suppressor genes using carbonate apatite inorganic nanoparticles Nabilah Ibnat, Monash University, Malaysia Title: Development of bio-functional inorganic nanoparticles for efficient delivery of siRNA, therapeutic gene and anticancer drug to breast cancer cells Jayalaxmi Shetty, Monash University School of Medicine, Malaysia Title: Losing the breast: A meta-synthesis of the impact in women breast cancer survivors Sun Lingshan, KK Women and Children Hospital, Singapore
Panel Discussion
Page 2
Day 2: March 13, 2018 Keynote Forum Title: Understanding RNA editing in human cancer: Causes and functional consequences Polly Leilei CHEN, Cancer Science Institute of Singapore, Singapore Title : Transketolase regulates dynamic switch of glucose metabolism to control breast cancer cell 10:15-11:00 metastasis via α-KG signaling pathway Cancer Cell Metastasis via α-KG Signaling Pathway Lu-Hai Wang, China Medical University, Taiwan Networking & Refreshments Break 11:00-11:15 @ Seletar Foyer Title: Primary malignant melanoma of the vagina in Bangladesh: Report of a case series and review of the 11:15-12:00 literature Shahana Pervin, National Institute of Cancer Research & Hospital, Bangladesh Sessions: Cancer Cell Biology |Cancer Epidemiology | Anticancer Drugs and New Formulations | Oncology Session Chair: Sudeep Kumar, Unichem Laboratories Ltd, India Session Co-Chair: Lu-Hai Wang, China Medical University, Taiwan Title: Aspirin inhibition of a novel target upstream of COX pathway leads to tumor regression in 12:00-12:30 oral squamous cell carcinoma Kshama Pansare, Tata Memorial Centre Advanced Centre for Treatment Research & Education in Cancer, India Lunch Break 12:30-13:30 @ Atrium Restaurant Title: GSTM1 and GSTT1 genetic susceptibility and interaction with chemical exposures in childhood 13:30-14:00 acute lymphoblastic leukemia: A systematic review and meta-analysis Samira B A Sesay, Zhengzhou Medical University, China Title: pH-responsive Doxorubicin-loaded cockle shell-derived nanoparticles: Release kinetics and 14:00-14:30 pharmacokinetics in canine Danmaigoro Abubakar, Universiti Putra Malaysia, Malaysia Title: EBNA2/c-Myc dependent regulation and adaptor function to LMP 1 in NF-κB signaling: MCT 1 14:30-15:00 and EBV- A first approach Suganya Sakthivel, Tzu Chi University, Taiwan Networking & Refreshments Break 15:00-15:30 @ Seletar Foyer Poster Presentation @ 15:30 –17:30 Title: The Potential role and mechanism of STAT3 in acquired resistance to EGFR TKI in lung adenocarcinoma with EGFR mutation GC–008 Chao Ting-Ting, Cardinal Tien Hospital, Taiwan Title: The proteins of retinoblastoma pahthway, FEN1 and MGMT are novel potential prognostic biomarkers in pancreatic adenocarcinoma GC–009 Joel Isohookana, Oulu University Hospital, Finland Title: EBNA2/c-Myc dependent regulation and adaptor function to LMP 1 in NF-κB signaling: MCT 1 and EBV- A first approach GC–010 Suganya Sakthivel, Tzu Chi University, Taiwan Title: Suppression of the Wnt/β-catein signaling pathway by Telectadium dongaiense with cytotoxic activities in colon cancer cells GC–011 Eun Seo Bae, Seoul National University, Korea Title: Targeting hypoxia-induced accumulation of HIF-1α and inducing apoptosis in human colorectal cancer cells by Salternamide A, a marine natural product isolated from halophilic Streptomyces Sp. GC–012 Jiyoung Hwang, Seoul National University, Korea Title: Regulating PI3K/AKT and ERK1/2 MAPK signal pathway by Naringenin induces mitochondria related apoptosis and ROS production in choriocarcinoma cells GC–013 Sunwoo Park, Korea University, Korea Title: Potential anticancer activity of Psammaplin A analogs derived from marine sponges in human lung cancer cells GC–014 Sunghwa Kim, Seoul National University, Korea Title: Application of Bayesian networks for prognosis of breast cancer patient’s outcomes GC–015 Gelena Guens, Moscow State University of Medicine and Dentistry, Russia 09:30-10:15
Award Ceremony Day 3: March 14, 2018 Business Networking and Lunch Page 3
